Isolation of Cognate RNA-protein Complexes from Cells Using Oligonucleotide-directed Elution
January 16th, 2017
8.7K views
This manuscript describes an approach to isolate select cognate RNPs formed in eukaryotic cells via a specific oligonucleotide-directed enrichment. We demonstrate the applicability of this approach by isolating a cognate RNP bound to the retroviral 5' untranslated region that is composed of DHX9/RNA helicase A.
Overview
This manuscript describes an RNA immunoprecipitation technique to selectively isolate and characterize endogenous RNA-protein complexes in eukaryotic cells. The method focuses on the retroviral 5' untranslated region and highlights the role of DHX9/RNA helicase A.
Key Study Components
Area of Science
- RNA biology
- Post-transcriptional control
- Viral gene expression
Background
- RNA-protein complexes play crucial roles in gene regulation.
- Understanding these complexes can provide insights into viral infections.
- Post-transcriptional control is vital for gene expression regulation.
- The five prime UTR is significant in retroviral transcripts.
Purpose of Study
- To isolate specific RNA-protein complexes using oligonucleotide-directed enrichment.
- To characterize the composition of RNA binding proteins in retroviral transcripts.
- To explore implications for viral infections and cellular diseases.
Methods Used
- RNA immunoprecipitation technique.
- Oligonucleotide-directed enrichment.
- Characterization of RNA binding proteins.
- Analysis of RNA-protein interactions.
Main Results
- Successful isolation of cognate RNPs bound to retroviral transcripts.
- Identification of DHX9/RNA helicase A in the isolated complexes.
- Insights into the mechanisms of post-transcriptional control.
- Potential identification of new drug targets for viral infections.
Conclusions
- The technique enhances understanding of RNA-protein interactions.
- It provides a framework for studying post-transcriptional regulation.
- Findings may lead to novel therapeutic strategies against viral diseases.
Frequently Asked Questions
What is RNA immunoprecipitation?
RNA immunoprecipitation is a technique used to isolate RNA-protein complexes from cells.
How does oligonucleotide-directed enrichment work?
It uses specific oligonucleotides to capture target RNA-protein complexes selectively.
What are the implications of this study?
The study provides insights into viral infections and potential drug targets.
What role does DHX9/RNA helicase A play?
DHX9/RNA helicase A is involved in the regulation of RNA-protein interactions.
Can this technique be applied to other RNA complexes?
Yes, it can be adapted to study various RNA-protein complexes in different contexts.
What is the significance of the five prime UTR?
The five prime UTR is crucial for regulating the expression of retroviral genes.
Executive Industry Relevance
This method enables selective isolation of specific RNA-protein complexes from eukaryotic cells, supporting target validation in post-transcriptional gene regulation. By enriching cognate RNPs at the 5' UTR of retroviral transcripts, it provides mechanistic insights into viral translation control and cellular stress response pathways. The approach aids in de-risking target hypotheses by defining RNP composition relevant to antiviral and disease-modifying strategies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by defining RNA binding protein composition at specific RNA elements.
- Operational Value: Supports biological de-risking through functional validation of RNA-protein interactions in disease-relevant contexts.
- Predictive Value: Enhances confidence in target selection by linking RNP complexes to translational control of viral and stress-response genes.
Screening & Assay Development
- Scientific Value: Prepares validated RNP complexes for downstream proteomic and biochemical analysis.
- Operational Value: Delivers reproducible, quantitative outputs suitable for assay standardization and screening readiness.
- Platform Value: Enables scalable isolation of cognate complexes for reliable compound evaluation in follow-up workflows.
Translational & Preclinical Research
- Scientific Value: Supports translational continuity by linking discovery-phase RNP identification to preclinical validation of gene regulation mechanisms.
- Operational Value: Facilitates risk-adjusted advancement decisions through mechanistic de-risking of post-transcriptional targets.
- Predictive Value: Aligns with biomarker development by identifying RNP components associated with pathogenic gene expression.
Pipeline & Workflow Integration
The technique fits within the discovery continuum from target hypothesis testing to lead identification, particularly for RNA-mediated mechanisms of gene expression.
- Discovery Biology: Supports hypothesis testing and pathway clarification by isolating specific RNP complexes from cellular lysates.
- Screening: Enables assay readiness through standardized isolation of RNA-protein complexes with defined composition.
- Analytics: Generates protein and RNA readouts that allow comparative analysis of RNP composition under varying conditions.
- Translational Research: Connects to preclinical continuity by providing mechanistic insight into viral and cellular gene expression control.
- Enterprise Reuse: Functions as a reusable platform for probing RNA-protein interactions across multiple targets and disease areas.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity in RNA-regulated pathways.
- Operational Value: Promotes standardization and reproducibility in RNP isolation across laboratories and projects.
- Strategic Value: Improves go/no-go decisions by enabling early de-risking of targets involved in post-transcriptional control.
- Portfolio Impact: Supports risk-adjusted prioritization of antiviral and cellular stress-response programs based on RNP composition data.
Implementation Considerations
- Requires expertise in molecular biology, immunoprecipitation, and RNA handling techniques.
- Depends on access to magnetic bead systems, centrifuges, and RNase-free laboratory equipment.
- Necessitates cross-team standardization of oligonucleotide design and RNase H digestion protocols.
- Involves adaptation considerations when applying to different RNA targets or cell types.
- Includes practical limitations such as the need for careful handling to preserve RNP integrity during lysis and elution steps.
Biopharma FAQs
Why does RNase H treatment matter for isolating cognate RNA-protein complexes?
RNase H cleaves the RNA in RNA-DNA hybrids, enabling release of the target RNP complex from the oligonucleotide-bound beads. This step is critical for isolating intact complexes bound to the 5' UTR of retroviral transcripts. The method relies on this cleavage to separate the RNP of interest from the capture oligonucleotide for downstream analysis.
How does immunoprecipitation of a FLAG-tagged protein support target validation in this workflow?
Immunoprecipitation of the FLAG-tagged MS2 protein captures the bait RNA and its associated RNP complex from cell lysates. This step enables selective enrichment of cognate RNPs bound to the retroviral 5' UTR. The approach validates target engagement by showing specific enrichment over IgG and negative controls.
What quantitative measurements enable assessment of RNP enrichment in the eluted fractions?
Western blot analysis detects enrichment of proteins like DHX9/RHA in the eluents compared to controls. RT-PCR and QRT-PCR measure recovery of the target RNA, confirming specific binding to the 5' UTR. These orthogonal readouts provide quantitative validation of RNP isolation efficiency and specificity.
Why are replication requirements important for cross-functional collaboration in RNP studies?
Replication ensures consistent isolation of cognate RNPs across experiments, supporting reliable data sharing between discovery and preclinical teams. Consistent results build confidence in target validation findings used for go/no-go decisions. The method’s reproducibility enables alignment across biology, screening, and translational science functions.
What statistical analysis capabilities are required before implementing this method in a discovery pipeline?
Basic statistical comparison of signal intensity between specific and control IPs (e.g., FLAG vs. IgG) is needed to assess enrichment significance. Quantitative western blot or PCR data should be analyzed for fold-change and variability across replicates. These analyses support objective interpretation of RNP composition data for target validation purposes.
